For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
BUT029
2,3-Butanediol, 1,4-dibromo-
[14396-65-7]
BUT031
Butanamide, N-[2-amino-6-methyl-4-(1-methyl-1H-benzimidazol-2-yl)phenyl]-
[1083158-65-9]
BUT032
Butanamide, N-[2-[[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]amino]-6-methyl-4-(1-methyl-1H-benzimidazol-2-yl)phenyl]-
[1098100-85-6]
BUT036
Butanamide, N-(4-bromo-2-methylphenyl)-
[363620-48-8]
BUT037
2-Butenoic acid, 4-(dimethylamino)-, (2E)-
[149586-32-3]
Hydrochloride [848133-35-7]
BUT044
1-Butanamine, N-butyl-N-(3-chloropropyl)-
[36421-15-5]
BUT048
3-Butenoic acid, 2-methyl-
[53774-20-2]
BUT050
2-Butenoic acid, 3-amino-2-methyl-, ethyl ester
[14369-90-5]
BUT051
Butane, 1-azido-4-chloro-
[671821-46-8]
BUT052
1-Butanone, 4-(methylamino)-1-(3-pyridinyl)-
[2055-23-4]
hydrochloride [16426-44-1]
BUT053
3-Buten-2-one, 4-ethoxy-3-(4-pyridinyl)-
88349-61-5
BUT054
Neratinib; 2-Butenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)-
[698387-09-6]
Maleate [915942-22-2]
CAR003
Carbamic acid, [2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-4,6,7,8,9,10-hexahydro-3-hydroxy-4-oxopyrimido[1,2-a]azepin-10-yl]methyl-, 1,1-dimethylethyl ester
[724446-08-6]
CAR004
Carbamic acid, N-(1-cyano-5-hydroxypentyl)-N-methyl-, 1,1-dimethylethylester
[724445-95-8]
CAR005
Carbamic acid, (3-methyl-1-oxido-2-pyridinyl)-, 1,1-dimethylethyl ester
[199296-32-7]
CAR006
Carbamic acid, (3-methyl-2-pyridinyl)-, 1,1-dimethylethyl ester
[138343-75-6]
CAR008
Carbamic acid, (5-methyl-2-pyridinyl)-, ethylester
[41322-67-2]
CAR009
Carbamic acid, (6-methoxy-2-pyridinyl)methyl-5,6,7,8-tetrahydro-2-naphthalenylester
[88678-34-6]
CAR010
Carbamic acid, N-[5-hydroxy-1-[(hydroxylamino)iminomethyl]pentyl]-N-methyl-, 1,1-dimethylethyl ester
[724445-97-0]
CAR011
Carbamic acid, N-[(1S)-1-[2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]butyl]-, 1,1-dimethylethyl ester
[856707-39-6]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help